Warner Bros. 'reviewing' new takeover bid from Paramount

Weather - Sydney 10°C

Warner Bros. 'reviewing' new takeover bid from Paramount

ECONOMY 24.02.2026

Warner Bros. 'reviewing' new takeover bid from Paramount / Photo: © AFP/File

Warner Bros. Discovery said Tuesday it has received a revised acquisition proposal from Paramount Skydance, even as the US media giant's board reaffirmed its support for a previously announced buyout deal with Netflix.

Change text size:

The sweetened offer was the latest instalment of a bidding war set to reshape Hollywood and US media, and has drawn White House attention, with President Donald Trump insisting he will have a say on the deal.

"We received a revised (Paramount) proposal to acquire WBD, which we are reviewing in consultation with our financial and legal advisors," the Warner Bros. board said, adding it would update shareholders once the review was complete.

Terms of Paramount's new offer were not disclosed, and the Warner Bros. board was careful to signal its preference for the rival Netflix deal.

The deal with the streaming giant "remains in effect" and directors "continue to recommend in favor of the Netflix transaction," the statement said.

Warner Bros. shareholders were advised to take no action with respect to the Paramount offer while the review is ongoing.

Paramount also confirmed the proposal and acknowledged that its sweetened bid could be countered by Netflix if the Warner Bros. board formally declared that Paramount's offer is a "superior proposal."

In its previous bid, Paramount Skydance had sought to buy all of Warner Bros. Discovery for $108 billion.

Though that was rebuffed by Warner's board, Paramount on Tuesday said it was still encouraging shareholders to back its offer, in what amounts to a hostile takeover attempt.

Paramount has also launched a lawsuit against Warner Bros. over an alleged lack of transparency in its dealings with Netflix.

Netflix is offering $83 billion for its more limited merger but is expected to be prepared to raise its offer to more closely match its rival's new bid.

The Netflix offer does not include Warner Bros. television properties such as CNN and Discovery, which would belong to a newly created publicly traded company if the deal is sealed.

Trump has said he will be "involved" in any decision on the merger, and the US Department of Justice is currently reviewing Netflix's proposed acquisition. European authorities and other regulators will also have their say.

Questions are swirling over whether politics will influence the outcome of the battle, with Paramount run by David Ellison and financed largely by his father, Oracle tycoon Larry Ellison, a longtime Trump ally.

A victory by Paramount would see CNN -- often the target of Trump's stinging threats and criticism -- pass to Ellison family control, amid criticism that their takeover of Paramount-owned CBS brought changes to the news division more to the White House's liking.

Trump late Saturday called on Netflix to fire board member Susan Rice or "pay the consequences," after she said Democrats would push for corporate accountability if they regain power in the November midterm elections.

"He likes to do a lot of things on social media. This is a business deal. It's not a political deal," Netflix co-CEO Ted Sarandos told BBC Radio 4, when asked about Trump's threat.

A.Wood--TNT

Featured

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

Change text size:

The National Times - Warner Bros. 'reviewing' new takeover bid from Paramount